Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental intranasal therapy reduced brain inflammation and was associated with ...

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Real-world data show Ocrevus reduced relapse rates and maintained disability stability in relapsing MS over four years.

Tech led the way on Wednesday as investors positioned themselves ahead of a wave of major earnings reports. The Nasdaq jumped 1.3% to 23,152, adding 288 points, while the Dow Jones climbed 0.6% to 49, ...

Ublituximab shows five year relapse reduction and disability benefits in multiple sclerosis, supporting early high efficacy treatment strategies today.

Actress Christina Applegate, best known for her roles in Married...With Children and Dead To Me, has been confined to her bed amid her battle with MS ...

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on ...

Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, ...

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved ...

New Zealand does not have enough neurologists to keep up with the increase in demand for the diagnosis and treatment of ...

Salesforce Inc (NYSE:CRM, XETRA:FOO) reports its fourth-quarter results after the bell on Wednesday, and the timing could not be more charged. The stock has spent the better part of a year under ...